We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Revolution in Rapid Testing: A New Generation of Programmable Lateral Flow Assays

By LabMedica International staff writers
Posted on 25 Oct 2021
Researchers have modified and enhanced the commonly used lateral flow assay method by introducing a technique to control the rate of capillary flow, which enables the test strip to carry out multistep chemical reactions following a programmed sequence.

Lateral flow assays (LFTs) have a wide array of applications and can be used to analyze a variety of samples such as urine, blood, saliva, sweat, serum, and other fluids. They are currently used by clinical laboratories, hospitals, and physicians for quick and accurate tests for specific target molecules and gene expression. Other uses for lateral flow assays are food and environmental safety and veterinary medicine for chemicals, diseases, and toxins. LFTs are also used for disease identification, but the most common LFT is the home pregnancy test.

A weakness of the conventional LFA method is that the physical characteristics of capillary flow prevents them from being able to coordinate complex processes that include the application of multiple reagents in a specific sequence with specific delays in between.

In response to this problem, investigators at the Georgia Institute of Technology (Atlanta, USA) recently described a way to control capillary flow by imprinting roadblocks on the flow path with water-insoluble ink and using the gradual formation of a void between a wetted paper and a sheath polymer tape to create timers. Timers were drawn at strategic nodes to hold the capillary flow for a desired period and thereby enabled multiple liquids to be introduced into multistep chemical reactions following a programmed sequence. By modifying the imprint geometry, the investigators could set the time required for a void to form and effectively created timers that blocked capillary flow for a desired duration.

The investigators employed the new technique to develope (i) an LFA with built-in signal amplification to detect human chorionic gonadotropin with an order of magnitude higher sensitivity than the conventional assay and (ii) a device to extract DNA from bodily fluids without relying on laboratory instruments. The latter device has potential for use as a rapid test for detection of Covid-19 infection.

"These tests have been extremely popular for years, mainly because they are so simple to use. You do not send anything to the lab or clinic because these tests do not require any external equipment to operate. This is an advantage," said senior author Dr. Fatih Sarioglu, assistant professor of electrical and computer engineering at the Georgia Institute of Technology. "But there also is a disadvantage. There are limitations to what they can do. By strategically imprinting these timers, we can program the assays to coordinate different capillary flows. That enables multiple liquids to be introduced, and multistep chemical reactions, with optimal incubation times - so, we can perform complex, automated assays that otherwise would normally have to be performed in laboratories. This takes us beyond the conventional LFA."

"We believe this flow technology research will have widespread impact," said Dr. Sarioglu. "This kind of dipstick test is so commonly used by the public for biomedical testing, and now it can be translated into other applications that we do not traditionally consider to be cut out for these simple tests."

The enhanced LFA technique was described in the October 1, 2021, online edition of the journal Science Advances.

Related Links:
Georgia Institute of Technology


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.